General Motors Company
Makes cars and trucks under several brands, with North American full-size pickups and SUVs carrying most of the profit.
Maintain GM at current $80-82 levels with a hard stop at $78.50, avoiding pre-earnings additions or trims given documented alpha-destruction patterns at both directional extremes. Stage scale-in triggers at $84.85 close on volume >1.5x average with MACD confirmation, with full reassessment at Q3 2026 earnings in mid-to-late October.
26 wins · 17 losses · 1 push in 44 scored verdicts How this is scored
Free accounts read most reports by the next trading session, every report within 7 days — subscribers read it the same day.
Create a free account-2.1%
Report archive
Subscribe to read
Subscribe to read
last 30 of 49 reports26 wins · 17 losses · 1 push in 44 scored verdicts-0.11% avg move
$10,000 → $9,788
-2.7%
$10,000 → $9,727
too few trades to judge — 1 round trip, 0 profitablein the market 1 of 18 sessionsmax drawdown -2.1%simulated 16 Sept – 9 Oct 20265 newer calls are locked
Simulated with a notional $10,000, fills at the next session's open, no commissions or slippage, split- and dividend-adjusted prices. Not a return forecast. How this is simulated
Subscribe to read
Subscribe to read
Subscribe to read
Maintain GM at current $80-82 levels with a hard stop at $78.50, avoiding pre-earnings additions or trims given documented alpha-destruction patterns at both directional extremes. Stage scale-in triggers at $84.85 close on volume >1.5x average with MACD confirmation, with full reassessment at Q3 2026 earnings in mid-to-late October.
Trim GM position 25-30% at current levels ($80.20-80.40), anchoring at the aggressive boundary to avoid repeating the -3.1% and -3.7% alpha destruction from prior insufficient-magnitude underweights; maintain 70-75% residual below-benchmark with a hard stop at $76.50. Do not add ahead of Q3 2026 earnings on October 22 due to elevated implied vol and likely conservative guidance making this a binary risk event, not a one-way revaluation catalyst. Re-entry requires price reclaiming and holding the 200 SMA at $80.37 with rising momentum, working capital stabilization, and macro relief (10Y rollover or rate-cut probability reset above 90% no-cut threshold).
Analyst maintains Hold on GM at ~$80.23, rejecting both aggressive pre-earnings additions (25-50%) and conservative reductions (20-30%), citing the 200 SMA defense at $80.37 as the key differentiator from prior Underweight calls and the 9/14-9/21 alpha-destruction pattern for Overweight. Stop tightened to $76.50 (below intraday low $76.91 and lower Bollinger $77.02), with post-earnings scale-in trigger at 10-15% add on close >$80.50 with RSI >50 and MACD histogram turning less negative; Q3 earnings in mid-to-late October is the binary reassessment checkpoint.
Reduce GM exposure by 55-65% (anchor at aggressive end) over 3-5 sessions, targeting a residual 35-45% of benchmark weight (1-2% portfolio weight), with a hard stop at $85.50 on the remaining position. The 200 SMA at $80.37 has been broken with confirmed bearish momentum (MACD -0.66 and expanding, RSI at 39), justifying the aggressive trim per binding 9/22-9/25 lessons. Do not initiate fresh shorts; Q3 2026 earnings (mid-to-late October) serves as the binary reassessment checkpoint with pre-committed bull/base/bear scenarios and explicit triggers.
Maintain Hold at the 200 SMA defense level ($80.39) with Q3 mid-October as the binary catalyst checkpoint; staged 1/3 adds on weekly reclaim above $80.39/$83/$85 on volume confirmation, with 25-33% trim on relief rally to $83-85 and 55-65% trim magnitude if price fails the 200 SMA and rolls below $78. Hard stop at $74.00 weekly close; pre-commit bull scenario (gross margin >9%, EPS >$2.50) → Overweight or bear scenario (margin <7.5%, guidance cut, forward EPS $12-13) → Underweight.
Maintain GM (GM) at current levels near $74-77 with a two-tier add protocol conditioned on 200 SMA reclaim at $80.39 and pre-committed Q3 reassessment scenarios—Hold prevents premature directional commitment in this 50/50 binary setup with bearish momentum intact but valuation floor (5.3x forward P/E, 0.27 PEG, sub-tangible-book) providing downside protection.
Analysts converge on SELL direction with debate focused on magnitude rather than direction; trim to 35-45% of benchmark weight anchored at the aggressive end to avoid repeating prior insufficient-underweight alpha destruction. Execute over 2-3 sessions at market into $80-81 weakness rather than waiting for a relief bounce, with hard stop at weekly close below $80.39 (200 SMA) on volume >10M shares and price target of $78.00.
Maintain GM at current levels near $80.50 with a hard stop at $79.85—a confirmed close below the 200 SMA on >15M shares triggers a trim to Underweight. The asymmetric risk/reward (~3% upside to 50 SMA at $85.46 vs ~7-10% downside on 200 SMA break) is unfavorable for new entries; Q3 2026 earnings in 3-4 weeks serves as the binary reassessment checkpoint.
Maintain GM at $80.64 with disciplined Hold as both directional extremes have historically destroyed alpha in this exact configuration. Stop at $79.50 defines ~1.04 ATR risk below the 200 SMA at $80.41, which has held for nine tests since May. Upgrade to Overweight requires 50 SMA reclaim at $85.36 with volume >10M, RSI >50, and MACD histogram contracting 3+ sessions; downgrade to Underweight triggers on weekly close below $80.00 on elevated volume, exposing $76-78 downside. Q3 2026 earnings (mid-October) is the binary reassessment checkpoint.
Trim GM to 35-45% of benchmark weight (55-65% trim magnitude) — the binding empirical record shows that 30-35% trims under-convert directional conviction into alpha. Execute over 2-3 sessions at market in the current $82-83 zone, avoiding the 9/17 trim-timing failure pattern; the trader's $82.50 fill target is rejected as over-engineered given elevated implied volatility into earnings. Hard stop is weekly close below $80.39 (200 SMA) on volume >10M shares — the 9/24 reflection proved that a daily close stop at $80 would have triggered on a 26-cent wick at the worst moment.
Maintain GM at current position size through the Q3 earnings binary catalyst with disciplined pre-committed scenarios—no adds below $85.05 reclaim on 50 SMA, full step-aside if $79.50 breaks on volume >10M, and 40-50% trim on bearish Q3 print. The Hold is empirically validated by prior alpha destruction patterns in both directions at this exact configuration, and position sizing must survive a 25% drawdown without forcing the stop.
Trim GM exposure to 0.65-0.70x benchmark weight (approximately one-third reduction) given bearish MACD crossover, RSI divergence, and Q3 2026 earnings ~5 weeks away. Hard stop at $79.50 (1.7 ATRs below current levels, just below the 200 SMA at $80.28) — a break on volume confirms regime change and warrants full exit. Re-entry triggers in order of preference: post-Q3 2026 earnings clean beat, capitulation flush to $75-78 on 10M+ share volume creating sub-7x forward earnings, or confirmed close above $87.76 with MACD histogram turning positive.
Reduce position 30-35% now at $83.45, capping residual exposure at ≤45% benchmark weight, with a hard stop at $80.28 (200-day moving average); a confirmed break below this level on volume exceeding 10M triggers full exit. Binary reassessment is scheduled at Q3 2026 earnings in mid-October, where bull metrics (gross margin >9%, EPS >$2.50) would warrant upgrade while bear metrics (gross margin <7.5%, EPS toward $10-11) would warrant downgrade to Sell targeting $75.
With GM trading at 5.6x forward P/E against a structurally rising 200 SMA ($80.24) and ~10.5% annualized buyback flow, initiate Overweight with a 1/4-size starter position at $83.95 and build to full size on either a daily close back above the 50 SMA ($84.82) with above-average volume or a retest down to $81 with rising volume—whichever triggers first—using a hard stop at $76.50 (~3 ATR below the 200 SMA floor).
Maintain underweight with 30-50% additional trim at current $83-85 levels rather than waiting for a potential $87-89 relief bounce that the bearish catalyst stack undermines; use a $86.50 stop and tiered management (cover half on break below $80.18 200 SMA, add other half on failed retest, full cover on close above $84.70 with volume and RSI confirmation). Hedge with a short-dated 78/72 put spread through Q3 earnings rather than expensive 18-month puts, reassessing after the mid-October binary print.
GM exposure should be trimmed from ~2% to 1.2–1.5% of portfolio, executed into any relief bounce toward the $87–$89 VWMA resistance zone rather than at current $86.62 spot, with a structural stop at $83.50 (~1 ATR below price and below September 9 swing low at $83.76). Re-entry is conditional on either a pullback to $80–$82 with the 200 SMA ($80.06) holding on a closing basis, or a Q3 2026 earnings print validating the $14.84 forward EPS bridge with gross margin >9%, EPS >$2.50, and operating income >$2.5B.
Reduce GM exposure by 30-50% of target weight to Underweight, selling into relief rallies toward the $85-87 VWMA resistance zone. Use a short-dated 78/72 put spread through Q3 2026 earnings rather than 18-month puts, with $87 stop-loss on new trim completions. Re-enter at $70-75 for materially better risk/reward, or upon forward EPS revisions toward $10-12 or confirmed retest of 200 SMA at $80.06 with bullish reversal candles.
Maintain current GM exposure through the mid-October Q3 2026 earnings print, which serves as the binary catalyst tiebreaker. Stop is tightened to $83.50 (~1 ATR below current price, below recent swing low at $83.42) per the 9/14 binding lesson that stops cannot sit at structural floor when momentum rolls negative on a high-beta cyclical ahead of dated catalyst. Add zone requires momentum-only confirmation at $88.14 breakout. Trim magnitude is calibrated to 15-20%, not 25-33%, per the 9/14 LMT cross-ticker lesson.
Maintain current GM exposure through mid-October Q3 2026 earnings print as the binary catalyst; the three-way analyst convergence on HOLD is binding, with the valuation anomaly (5.87x forward P/E, ~28% FCF yield, $8.8B LTM buybacks) balanced against deteriorating EPS trajectory (Q1 $2.82 → Q2 $1.41). Stop placement at $79 (200 SMA), not position-size reduction, carries the downside protection per the 9/10 lesson; the add zone relaxes to momentum-only confirmation rather than requiring defended higher-low structure that never materialized.
Maintain current GM exposure without trimming or adding as the 9/9 Underweight call (-3.4% alpha, +2.8% absolute) demonstrated that lighter-touch positioning outperforms when the 200 SMA structural floor at $79.77 is intact and the Q3 2026 binary catalyst is six weeks away. Tighten protective stop to $83.50 (just below the 50 SMA at $83.62), deferring all adds until either a confirmed close above $88.90 on volume >8M with MACD histogram turning positive, or Q3 earnings validates the $14.84 forward EPS bridge.
Maintain HOLD rating with three-way analyst convergence as the binding signal. The 9/9 Underweight reflection lesson is clear: when the 200 SMA floor is intact and the binary catalyst (Q3 2026 earnings) is months away, relief bounces off technical defenses are the modal outcome, making no-trim the correct positioning. New capital deploys in three tranches—1/3 at $79-83 contingent on 200 SMA holding, 1/3 on confirmed close above $90.96 with volume >8M, and 1/3 reserved for either follow-through confirmation or Q3 2026 earnings beat—whichever comes first.
Reduce GM exposure to 50-75% of benchmark (anchored at ~75%) via tranche approach over 1-2 weeks, trimming opportunistically on relief bounces into the $87-$89 resistance zone rather than at the current $83.76 tape, with hard stop at $79.51 (200 SMA) defining structural thesis invalidation and Q3 2026 earnings as the binary reassessment checkpoint.
Reduce GM to 50-75% of benchmark (anchored ~75%) rather than full exit, waiting for confirmed tests of $88.90-$90.11 resistance before trimming additional 25%. Hard stop at $79.50 close below 200 SMA with re-engagement only on daily close above $90.11 on rising volume with positive MACD histogram. Q3 2026 earnings (mid-October) serves as binary reassessment checkpoint with upgrade triggers at gross margin >10% for two consecutive quarters or confirmed close above $91.85, and downgrade triggers at close below $79.50 with gross margin <7% guidance cut.
All three analysts converge on Hold for GM at ~$84.87 given the 5.91x Forward P/E valuation anomaly and structural floor intact at $79.48 (rising 200 SMA), with momentum deterioration (MACD histogram at -0.38, RSI at 47.58 sliding from 73.7, below 10 EMA at $85.94) precluding new buying. Active trigger framework uses $81.50-$82 protective stop (tightened above trader's $77), $79-82 add zone requiring momentum confirmation (defended higher-low, MACD turning toward zero, RSI above 50), and Q3 2026 earnings (mid-October) as binary reassessment catalyst where gross margin >9% with EPS >$2.50 would upgrade to Buy versus <7.5% gross margin with guidance cut triggering Underweight.
Initiate phased Overweight position with 0.50-0.75% initial tranche at $82.50 and 0.25% reserve tranche contingent on momentum confirmation above $86.36 (MACD histogram turning positive). Hard stop set at $79.48 (200 SMA, closing basis) with position cap at 1.0%. Q3 2026 earnings (late October) serves as binary reassessment checkpoint: gross margin >9% with EPS >$2.50 triggers upgrade to Buy, while gross margin <7.5% with guidance cut warrants downgrade.
Initiate or add to GM with phased accumulation (35-40% initial tranche at $85-86) calibrated to the constructive structural thesis (5.7x forward P/E, 9.2% share count reduction, $7-9B annual buyback) while respecting technical deterioration (RSI 73→50, MACD bearish, lower highs) and the approaching Q3 earnings binary catalyst in late October. Hard stop at $78.50 (below 200 SMA) to invalidate the structural thesis, with subsequent tranches reserved for confirmation at the 50 SMA ($82.73) or 200 SMA ($79.34) if reached.
Maintain GM at ~$85 with Active Hold framework across all three analyst positions. The bear won the earnings debate (Q2 EPS $1.41 vs bull's sustainable run-rate thesis), but structural arguments retain merit with 37% share count reduction, $26.87B OCF, and rising 200 SMA at $79.34. Use Q3 2026 earnings (late October) as the decisive reassessment checkpoint.
Maintain GM at $86.32 with an ACTIVE Hold framework—neither trim nor add—based on the binding 8/27 GM Underweight lesson that penalized 40-50% trim when structural floors hold and catalysts are months away. Use $79.20 (200 SMA) as the structural stop; confirmed close below $82.60 (50 SMA) on volume >10M triggers 25% asymmetric trim, not the heavier 50-70% correction the conservative analyst recommends. Aug 29-30 Unifor ratification and late-October Q3 2026 earnings are the binary reassessment checkpoints; risk/reward to the $94.19 target vs $79.20 stop (~1.2:1) is too weak for fresh longs but structural FCF ($21.9B TTM) and buyback engine ($8.8B) support holding rather than full exit.
Trim GM to 50–55% of benchmark weight at market ($86–87), reducing 40–45% of the current position; the forward EPS bridge math shows annualized Q1+Q2 2026 EPS of $8.46 versus $14.85 consensus, and the catalyst stack—including the L87 probe, brake-by-wire investigation, Canada tariff binary on Jan 1, 2027, and $37B refinancing against 5.8x net leverage—is asymmetric and unresolved. Layer December $80/$85 put protection on ~20% of the residual position, with a hard stop at $78.93 (200 SMA) and trim trigger at $82.60 (50 SMA) on volume.
Reduce GM exposure by 40-50% at current levels (~$86), targeting 50-55% of benchmark weight, with a $80.50 hard structural stop above the 200 SMA. Layer January 2027 $80-$85 put protection on 25-30% of the remaining position to bracket the binary USMCA tariff catalyst, avoiding the $83.50-$84.00 add zone ahead of this dated event. Re-entry requires confirmation of January 2027 tariff resolution and forward EPS stabilization, not just technical pullbacks.
Maintain GM at Hold with active sizing rules rather than passive patience, using the $79 stop-loss as the primary risk boundary. Scale adds on defended higher-low at $82-84 with MACD histogram turning toward zero; trim 15-20% opportunistically into $89-90 strength; avoid new positions exceeding 50% of normal cyclical-auto allocation until catalysts (Unifor ratification Aug 29-30, Canada tariff trajectory, NHTSA brake probe, Q3 deliveries, Q3 earnings) provide directional clarity.
Maintain GM at $85.81 with an Active Hold rating and three pre-committed triggers: add on pullback to $82-84 with higher-low defense and MACD histogram turning (stop $79), upgrade to Buy on clean close above $90.30 with volume >1.3x average (stop $84.50), or exit fully on confirmed close below $79 on volume >10M. Key reassessment checkpoints are Aug 29-30 Unifor ratification and October Q3 2026 earnings; a clean tariff de-escalation above the ~70% implementation probability would signal green light for fresh capital.
Trim GM to 50-55% of benchmark weight from current levels, with stop loss at $78.93 (200 SMA) and a ~25% hedge using $80-strike puts. The 5.86x forward P/E is built on $14.85 consensus EPS that has not absorbed the 50% Canadian tariff drag expected in Q3/Q4 2026, creating re-rating risk. Reassess after the Aug 29-30 Unifor ratification (binary catalyst) and Q3 earnings, with full exit triggered by a confirmed close below $78.93 on volume exceeding 10M shares.
Maintain current GM position as the validated Hold posture, given configurationally identical setup to the August 20 setup that produced +1.7% alpha, with the NHTSA probe remaining unprocessed and zero follow-through sessions confirming buyer absorption. Structural valuation is attractive (5.92x forward P/E, 0.34 PEG, $21.9B FCF) but tactical momentum remains deteriorating (MACD bearish, RSI mid-40s, price below 10 EMA), warranting patience over fresh capital deployment until either upgrade trigger (close above $90.85 on volume with MACD histogram cross positive) or downgrade trigger (confirmed close below $50 SMA at $82 on volume >10M) is confirmed.
Maintain the current GM position at $82.50 while holding stop at $78.73 (200 SMA); trim 15-20% only on confirmation of strength at $88-90, not pre-positioned. Do not add fresh capital without a MACD bullish re-cross and VWMA reclaim. The prior decision record validates Hold as the correct posture for this setup—structural floor defended but momentum deteriorating into Q3 2026 earnings as a binary catalyst. The probability-weighted outcome is range-bound drift, not directional resolution.
GM receives an Overweight rating with a 3-4% initial position in the $81.90-$84.00 zone (6% max), justified by compelling structural valuation (5.78x forward P/E, $6B+ in buybacks, $26.9B operating cash flow) despite real but non-regime-changing momentum deterioration; staged entries and exits at $86.72, $90.30, and $92.06 with a hard stop at $80.50 provide disciplined risk management around the Q3 2026 earnings binary.
Trim General Motors to Underweight by 25% (low end of the 8/14 validated 25-35% range) ahead of the Aug 19 tariff deadline, with a hard stop at $78.56 (200 SMA) on the residual position. The Q3 2026 earnings (October) serves as the binary validation event—if gross margin recovers above 9% and operating income exceeds $2.5B, the structural thesis is validated and warrants upgrade; if margins deteriorate below 7.5% with a guidance cut, full exit is triggered.
Trim GM exposure 35-45% to address five-vector deterioration (MACD bearish cross, price below 10 EMA and Bollinger middle band, overhead VWAP resistance, FCF coverage gap, and margin deterioration) with convexity into the Aug 19 Canada tariff binary event and Q3 earnings. Maintain hard stop at $81.50 on residual position; full exit triggered by confirmed close below 50 SMA on volume >10M, or Q3 miss with gross margin below 7.5% and guidance cut. Re-engage only on a flush to $76-78 (200 SMA zone) or two consecutive quarters of YoY margin recovery AND inventory normalization toward $14B.
Reduce GM exposure by 25-35% via opportunistic trimming at $87.13 (10 EMA) and $88.47 (VWMA), where recent buyers remain underwater. Maintain hard stop at $81.50 on any residual long — a confirmed close below the 50 SMA on volume >10M triggers full exit. Do not initiate new longs; re-entry requires either a flush to the $76-78 zone or two consecutive quarters of YoY margin recovery with inventory normalization toward $14B.
Maintain Hold on GM at $86.39 as the structural undervaluation case (5.87x Forward P/E, $21.93B TTM FCF, 8.3% share count reduction) is compelling but undermined by deteriorating momentum signals—MACD bearish crossover, price below 10 EMA at $87.21, and declining volume—with a binary Q3 2026 earnings catalyst ahead; stage entries at $82-84 on 10 EMA reclaim with volume >5M and at $78-80 on 200 SMA test with RSI reset to 40-45, with a hard stop at $81.50 and full exit trigger below on volume >10M.
Trim GM by 20-25% to reduce Beta 1.33 convexity ahead of the binary Q3 earnings catalyst, while preserving the structural thesis intact (5.9x Forward P/E, $21.9B FCF, capital return program). Maintain the $81.50 hard stop and re-engage on Tier 1 (above $90.30 on volume ≥8M with MACD histogram re-acceleration), Tier 2 (defended 50 SMA retest at $81.64 with bullish reversal), or Tier 3 (Q3 beat with gross margin recovery above 9%).
Maintain a neutral HOLD on GM with a ~25% pre-CPI trim at current levels ($89.35, 97% of 52-week high) to reduce convexity exposure into the binary catalyst. Primary breakdown trigger is a confirmed close below the 50 SMA at $81.55 on volume >10M shares, which would warrant an additional 25-30% trim, while re-engagement awaits either a breakout above $90.30 with MACD re-acceleration targeting $94.19, or Q3 earnings validation confirming whether the 7.6% gross margin was an anomaly or structural deterioration.
Hold GM at ~$87.96 as the confirmed uptrend and anomalous valuation (5.95x Forward P/E, 0.35 PEG) are offset by fading momentum (MACD histogram -74% in 5 sessions, volume declining from 13.38M to 2.60M) and 50% gross profit collapse. Use a tiered discipline framework: trim 25-33% if price closes below $85.35 (1 ATR) on volume, exit remainder if $79.50 gap fill breaks, with Q3 2026 earnings (late Oct/early Nov) as the binary validation event for the $14.71 EPS thesis.
Maintain GM at ~$87.58 with HOLD rating as the valuation cushion (Forward P/E 5.95x, PEG 0.35, TTM FCF $21.93B, $8B debt reduction, $6.3B annualized buybacks) is offset by deteriorating momentum (MACD histogram -78% in 9 sessions, three failed retests of $91.85, Q1→Q2 sequential net income decline of 50%, $1.5B inventory build). Stop refined to ~$84.50, with trim rule added if 50 SMA at $81.35 fails on rising volume.
Get the daily brief — how yesterday's calls actually scored, in your inbox before the open — free with a TraderPunk account.
Create a free accountAlready have one? Sign in to subscribe.